Free tool

Diagnostics stocks

We cover 14 companies grouped under the Diagnostics theme. The median market value in the group is $3.87B. Across the group, the median move over the past trading day is −0.20%. Price change over the past year runs from −24.4% to +142.7% across the middle 80 percent of the group, with a median of +12.9%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

14 of 150 companies match these filters.Clear filters

TickerCompanyPrice1M returnYTD return1Y returnNext report
QGENQiagen N.V.$43.36+2.55%−4.05%−9.65%Nov 4, 2026
QIA.DEQiagen N.V.36.71 EUR−0.60%−3.76%−6.73%Nov 4, 2026
ALQ.AXALS Limited22.37 AUD+5.32%+1.41%+22.07%Nov 23, 2026
CAICaris Life Sciences, Inc.$26.82+72.03%−0.59%−29.83%Nov 4, 2026
6869.TSysmex Corporation1,915.50 JPY+14.53%+26.54%+3.66%Nov 4, 2026
BLLNBillionToOne, Inc.$96.22−28.00%+7.76%−11.68%Nov 5, 2026
ADPTAdaptive Biotechnologies Corporation$26.16+16.16%+64.42%+101.70%Nov 4, 2026
VCYTVeracyte, Inc. Common Stock$44.29−20.41%+4.48%+54.81%Nov 3, 2026
GRALGRAIL, Inc.$79.59+23.55%−10.44%+136.66%Nov 11, 2026
WGSGeneDx Holdings Corp.$90.29+45.90%−31.76%−30.11%Oct 27, 2026
CDNACareDx, Inc.$50.96+42.55%+166.25%+283.45%Nov 3, 2026
NEOGNeogen Corporation$11.70+27.31%+67.14%+103.83%Oct 8, 2026
NEONeoGenomics, Inc.$17.37+29.63%+47.70%+145.34%Oct 27, 2026
ALIF-B.STAddLife AB (publ)162.30 SEK+0.87%+8.17%−7.20%Oct 21, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse